RBPMS, an RNA-binding protein, and MET, a proto-oncogene receptor tyrosine kinase, have been identified as fusion partners in a variety of cancers with other genes and as gene fusion partners in a patient with cholangiocarcinoma [37]. Here, MET is linked to cancer.